Pursue Remission

Dr Carol Wallace

Dr. Wallace is professor of pediatric rheumatology at Seattle Children’s Hospital and Regional Medical Center and University of Washington School of Medicine. She received her MD from the University of Michigan and completed her pediatrics residency and pediatric rheumatology fellowship at the University of Washington. She was in private practice pediatrics and rheumatology until she joined Children’s Hospital and Regional Medical Center and the University of Washington in 1984.

Dr. Wallace’s main focus is the aggressive treatment of JIA and other pediatric rheumatic diseases. She has published many of the sentinel studies of methotrexate use in JIA treatment and is a principal investigator of a multicenter trial of early aggressive therapy for JIA. She helped develop an international consensus definition for remission of JIA. Her committee positions have included the Pediatric Rheumatology Sub-board for the American Board of Pediatrics and subcommittees of the ACR, and the Advisory Committee of the Pediatric Rheumatology Collaborative Study Group. She is chair of the Childhood Arthritis and Rheumatology Research Alliance.

References

1. Wallace CA, Huang B, Bandeira M, et al. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. Arthritis Rheum. 2005;52:3554-3562.
2. Wallace CA. The use of methotrexate in childhood rheumatic diseases. Arthritis Rheum.1998;41:381-391.
3. Lovell DJ, Reiff A, Jones OY, et al. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum. 2006;54:1987-1994.
4. Rossi F, Di Dia F, Galipò O, et al. Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. Arthritis Rheum. 2006;55:717-723.
5. Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007; 34:1133-1138.
6. Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporin. J Pediatr.1996;128:275-278.
7. Wallace CA, Ruperto N, Giannini EH, et al. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol. 2004;31:2290-2294.